DEVELOPMENT OF FORMULATION OF SUPPOSITORY CONTAINING AZITHROMYCIN 100 MG

Thi My Duyen Huynh1,, Thi Minh Ngoc Le1
1 Cantho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Azithromycin (AZI) is an antibiotic with strong antibacterial activity against bacteria causing diseases in the respiratory tract. However, its solubility in water is poor, so the bioavailability is low. Furthermore, its taste is extremely bitter, making it unsuitable for oral dosage forms, especially for children. A suppository is a drug form that helps substances increase the absorption into the circulation through the rectal venous system and helps to overcome active ingredients' bitter tastes appearing when administered orally. Objectives: research on a process to quantify azithromycin by the high-performance liquid chromatography method. Development of the formulation of the suppository containing azithromycin 100 mg with the support of software for designing and optimizing. Materials and research method: azithromycin dihydrate, excipients, and experimental research on designed formulations. Results: a procedure for quantifying azithromycin by the high-performance liquid chromatography method has been established. The formulation of the suppository containing azithromycin 100 mg consisted of azithromycin dihydrate (104.81 mg), PEG 4000 (740.54 mg), PEG 400 (587.13 mg), glycerin (639.37 mg), beeswax (106.15 mg), and tween 80 (22 mg). Conclusion: the suppository containing azithromycin 100 mg had the base of a combination of PEGs, glycerin, and lipophilic excipients, which produces an emulsion-like structure. The finished product had no phase separation and had a melting point of about 48 oC. Also, the percentage of its in vitro solubility was 49.5 % at 30 minutes.

Article Details

References

1. Hà Diệu Ly, Dương Công Minh, Nguyễn Thị Duyên, Võ Thị Hoàng Yến (2002), “Định lượng Azithromycin trong viên bao phim Azithral bằng phương pháp HPLC với detector UV trên cột pha đảo”, Tạp chí kiểm nghiệm thuốc, tập 3 (9), 10-12.
2. European Pharmacopoiea Commission (2008), European Pharmacopoiea, 32-34.
3. Gandhi, R., et al (2002), Characterization of Azithromycin hydrates, European Journal of Pharmaceutical Sciences, 16(3), pp. 175-184.
4. Happiness Mollel (2006), Development and assessment of Azithromycin paediatric suppository formulations, Faculty of Pharmacy, Rodes university, Grahamstown, South Africa.
5. Harris, M., et al (2011), British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011, Thorax, 66(2), pp. ii1-ii23.
6. ICH (2005), Validation of Analytical Procedures: Text and Methodology Q2 (R1).
7. Shaheen SM., et al (2005), Application of a few Waxy materials on the realease of Naproxen from Polyethylen glycol based suppositories, Pakistan Journal of Biological Science, 8(12), pp.1685-1689.
8. Zubata, P., et al (2002), A new HPLC method for azithromycin quantitation, Journal of Pharmaceutical and Biomedical Analysis, 27(5), pp. 833-836.
9. http://kttvqg.gov.vn/du-bao-107/chuyen-gia-khi-tuong--nhiet-do-se-cao-ky-luc-trong- thang-tam-10022.html (ngày truy cập: 3/11/2021).
10. https://hoihohapvietnam.org/detail. (ngày truy cập: 25/1/2022).